Avalon Globocare Corp (ALBT) USD0.0001

Sell:$3.42Buy:$3.71$0.32 (9.28%)

Prices delayed by at least 15 minutes
Sell:$3.42
Buy:$3.71
Change:$0.32 (9.28%)
Prices delayed by at least 15 minutes
Sell:$3.42
Buy:$3.71
Change:$0.32 (9.28%)
Prices delayed by at least 15 minutes

Company Information

About this company

Avalon GloboCare Corp. is a commercial-stage company engaged in developing and delivering precision diagnostic consumer products and the advancement of intellectual property in cellular therapy. The Company operates in two reportable business segments: the real property operating segment and the laboratory testing services segment. Its laboratory services offer a test menu that satisfies the clients' testing needs, from general bloodwork to anatomic pathology, urine toxicology, pharmacogenomics (PGx) testing and more, and it is a one-stop-shop for clinical testing. The Company is currently marketing the KetoAir breathalyzer device and plans to develop additional diagnostic uses of the breathalyzer technology. The KetoAir breathalyzer is a handheld device that allows the user to detect acetone levels in exhaled breath. The acetone level is in concentration units part-per-million (ppm) such that the user knows the real-time ketosis status.

Key people

Wenzhao Lu
Chairman of the Board of Directors
David Jin
President, Chief Executive Officer, Director
Luisa Ingargiola
Chief Financial Officer
Meng Li
Chief Operating Officer, Company Secretary
Wilbert J. Tauzin
Director
Lourdes Felix
Independent Director
Steven Andrew Sanders
Independent Director
William B. Stilley
Independent Director
Tevi Troy
Independent Director
Click to see more

Key facts

  • EPIC
    ALBT
  • Location
    United States
  • Sector
    Healthcare
  • Industry
    Medical Equipment & Supplies
  • ISIN
    US05344R3021
  • Market cap
    $5.47m
  • Employees
    5
  • Shares in issue
    1.66m
  • Exchange
    NASDAQ
  • Index

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.